Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 1
2004 5
2005 2
2006 10
2007 14
2008 12
2009 6
2010 5
2011 9
2012 7
2013 9
2014 13
2015 5
2016 2
2017 8
2018 5
2019 8
2020 9
2021 11
2022 10
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

141 results
Results by year
Filters applied: . Clear all
Page 1
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma.
Wu RY, Kong PF, Xia LP, Huang Y, Li ZL, Tang YY, Chen YH, Li X, Senthilkumar R, Zhang HL, Sun T, Xu XL, Yu Y, Mai J, Peng XD, Yang D, Zhou LH, Feng GK, Deng R, Zhu XF. Wu RY, et al. Among authors: senthilkumar r. Clin Cancer Res. 2019 Jul 15;25(14):4530-4541. doi: 10.1158/1078-0432.CCR-18-2840. Epub 2019 Apr 2. Clin Cancer Res. 2019. PMID: 30940655
Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study.
Raghavan K, Dedeepiya VD, Suryaprakash V, Rao KS, Ikewaki N, Sonoda T, Levy GA, Iwasaki M, Senthilkumar R, Preethy S, Abraham SJ. Raghavan K, et al. Among authors: senthilkumar r. Biomed Pharmacother. 2022 Jan;145:112243. doi: 10.1016/j.biopha.2021.112243. Epub 2021 Sep 25. Biomed Pharmacother. 2022. PMID: 34840031 Free PMC article. Clinical Trial.
A rare cause of nephrotic syndrome.
Thomas RG, Senthilkumar RP, Velayudham B, Vasudevan C, Murugesan T. Thomas RG, et al. Among authors: senthilkumar rp. Saudi J Kidney Dis Transpl. 2020 May-Jun;31(3):676-680. doi: 10.4103/1319-2442.289453. Saudi J Kidney Dis Transpl. 2020. PMID: 32655053
β‑glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B‑VACCIEN) in specific immunocompromised populations (Review).
Ikewaki N, Dedeepiya VD, Raghavan K, Rao KS, Vaddi S, Osawa H, Kisaka T, Kurosawa G, Srinivasan S, Kumar SRB, Senthilkumar R, Iwasaki M, Preethy S, Abraham SJK. Ikewaki N, et al. Among authors: senthilkumar r. Oncol Rep. 2022 Jan;47(1):14. doi: 10.3892/or.2021.8225. Epub 2021 Nov 15. Oncol Rep. 2022. PMID: 34779494 Review.
Laparoscopic management of hepatic hydatid disease.
Palanivelu C, Jani K, Malladi V, Senthilkumar R, Rajan PS, Sendhilkumar K, Parthasarthi R, Kavalakat A. Palanivelu C, et al. Among authors: senthilkumar r. JSLS. 2006 Jan-Mar;10(1):56-62. JSLS. 2006. PMID: 16709359 Free PMC article. Review.
Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis.
Preethy S, Raghavan K, Dedeepiya VD, Surya Prakash V, Ikewaki N, Ikeue Y, Nagataki M, Iwasaki M, Senthilkumar R, Abraham SJK. Preethy S, et al. Among authors: senthilkumar r. Front Immunol. 2022 Jun 27;13:870632. doi: 10.3389/fimmu.2022.870632. eCollection 2022. Front Immunol. 2022. PMID: 35833122 Free PMC article. Review.
141 results